Logo image of ACCB.BR

ACCENTIS NV (ACCB.BR) Stock Fundamental Analysis

EBR:ACCB - Euronext Brussels - BE0003696102 - Common Stock - Currency: EUR

0.0315  +0 (+3.28%)

Fundamental Rating

5

Taking everything into account, ACCB scores 5 out of 10 in our fundamental rating. ACCB was compared to 69 industry peers in the Real Estate Management & Development industry. ACCB gets an excellent profitability rating and is at the same time showing great financial health properties. ACCB has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

8

1. Profitability

1.1 Basic Checks

In the past year ACCB has reported negative net income.
In the past year ACCB had a positive cash flow from operations.
In the past 5 years ACCB has always been profitable.
In the past 5 years ACCB always reported a positive cash flow from operatings.
ACCB.BR Yearly Net Income VS EBIT VS OCF VS FCFACCB.BR Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 5M 10M 15M

1.2 Ratios

Looking at the Return On Assets, with a value of 3.42%, ACCB belongs to the top of the industry, outperforming 84.00% of the companies in the same industry.
ACCB's Return On Equity of 5.19% is fine compared to the rest of the industry. ACCB outperforms 77.33% of its industry peers.
Looking at the Return On Invested Capital, with a value of 3.80%, ACCB belongs to the top of the industry, outperforming 81.33% of the companies in the same industry.
ACCB had an Average Return On Invested Capital over the past 3 years of 4.14%. This is in line with the industry average of 4.12%.
Industry RankSector Rank
ROA 3.42%
ROE 5.19%
ROIC 3.8%
ROA(3y)6.6%
ROA(5y)5.89%
ROE(3y)8.8%
ROE(5y)9.14%
ROIC(3y)4.14%
ROIC(5y)4%
ACCB.BR Yearly ROA, ROE, ROICACCB.BR Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 5 10 15

1.3 Margins

The Profit Margin of ACCB (31.12%) is better than 84.00% of its industry peers.
In the last couple of years the Profit Margin of ACCB has remained more or less at the same level.
ACCB has a better Operating Margin (62.86%) than 86.67% of its industry peers.
ACCB's Operating Margin has improved in the last couple of years.
ACCB has a Gross Margin of 64.02%. This is in the better half of the industry: ACCB outperforms 66.67% of its industry peers.
ACCB's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 62.86%
PM (TTM) 31.12%
GM 64.02%
OM growth 3Y3.86%
OM growth 5Y3.06%
PM growth 3Y8.69%
PM growth 5Y0.55%
GM growth 3Y3.54%
GM growth 5Y2.81%
ACCB.BR Yearly Profit, Operating, Gross MarginsACCB.BR Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 20 40 60 80

8

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), ACCB is destroying value.
Compared to 1 year ago, ACCB has about the same amount of shares outstanding.
ACCB has less shares outstanding than it did 5 years ago.
ACCB has a better debt/assets ratio than last year.
ACCB.BR Yearly Shares OutstandingACCB.BR Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 200M 400M 600M 800M 1B
ACCB.BR Yearly Total Debt VS Total AssetsACCB.BR Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 50M 100M

2.2 Solvency

An Altman-Z score of 2.17 indicates that ACCB is not a great score, but indicates only limited risk for bankruptcy at the moment.
The Altman-Z score of ACCB (2.17) is better than 89.33% of its industry peers.
ACCB has a debt to FCF ratio of 4.43. This is a neutral value as ACCB would need 4.43 years to pay back of all of its debts.
The Debt to FCF ratio of ACCB (4.43) is better than 94.67% of its industry peers.
A Debt/Equity ratio of 0.31 indicates that ACCB is not too dependend on debt financing.
Looking at the Debt to Equity ratio, with a value of 0.31, ACCB is in the better half of the industry, outperforming 77.33% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.31
Debt/FCF 4.43
Altman-Z 2.17
ROIC/WACC0.59
WACC6.46%
ACCB.BR Yearly LT Debt VS Equity VS FCFACCB.BR Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 20M 40M 60M 80M

2.3 Liquidity

ACCB has a Current Ratio of 5.39. This indicates that ACCB is financially healthy and has no problem in meeting its short term obligations.
The Current ratio of ACCB (5.39) is better than 90.67% of its industry peers.
A Quick Ratio of 5.39 indicates that ACCB has no problem at all paying its short term obligations.
Looking at the Quick ratio, with a value of 5.39, ACCB belongs to the top of the industry, outperforming 93.33% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 5.39
Quick Ratio 5.39
ACCB.BR Yearly Current Assets VS Current LiabilitesACCB.BR Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 20M 40M 60M

1

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 128.57% over the past year.
Measured over the past years, ACCB shows a very negative growth in Earnings Per Share. The EPS has been decreasing by -18.39% on average per year.
ACCB shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -13.03%.
The Revenue for ACCB have been decreasing by -19.00% on average. This is quite bad
EPS 1Y (TTM)128.57%
EPS 3Y-23%
EPS 5Y-18.39%
EPS Q2Q%-55.56%
Revenue 1Y (TTM)-13.03%
Revenue growth 3Y-29.62%
Revenue growth 5Y-19%
Sales Q2Q%-13.89%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
ACCB.BR Yearly Revenue VS EstimatesACCB.BR Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 5M 10M 15M 20M
ACCB.BR Yearly EPS VS EstimatesACCB.BR Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023

2

4. Valuation

4.1 Price/Earnings Ratio

Industry RankSector Rank
PE N/A
Fwd PE N/A
ACCB.BR Price Earnings VS Forward Price EarningsACCB.BR Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

ACCB's Price/Free Cash Flow ratio is a bit cheaper when compared to the industry. ACCB is cheaper than 76.00% of the companies in the same industry.
Industry RankSector Rank
P/FCF 12.73
EV/EBITDA N/A
ACCB.BR Per share dataACCB.BR EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0.01 0.02 0.03

4.3 Compensation for Growth

ACCB has an outstanding profitability rating, which may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

ACCB does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

ACCENTIS NV

EBR:ACCB (3/6/2025, 7:00:00 PM)

0.0315

+0 (+3.28%)

Chartmill FA Rating
GICS SectorReal Estate
GICS IndustryGroupEquity Real Estate Investment Trusts (REITs)
GICS IndustryReal Estate Management & Development
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst OwnersN/A
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap39.78M
AnalystsN/A
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend0
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 6.15
P/FCF 12.73
P/OCF 12.6
P/B 1.02
P/tB 1.02
EV/EBITDA N/A
EPS(TTM)0
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)0
FCFY7.86%
OCF(TTM)0
OCFY7.93%
SpS0.01
BVpS0.03
TBVpS0.03
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 3.42%
ROE 5.19%
ROCE 7.36%
ROIC 3.8%
ROICexc 5.69%
ROICexgc 5.69%
OM 62.86%
PM (TTM) 31.12%
GM 64.02%
FCFM 48.31%
ROA(3y)6.6%
ROA(5y)5.89%
ROE(3y)8.8%
ROE(5y)9.14%
ROIC(3y)4.14%
ROIC(5y)4%
ROICexc(3y)7.12%
ROICexc(5y)5.82%
ROICexgc(3y)7.12%
ROICexgc(5y)5.82%
ROCE(3y)8.02%
ROCE(5y)7.72%
ROICexcg growth 3Y9.7%
ROICexcg growth 5Y5.44%
ROICexc growth 3Y9.7%
ROICexc growth 5Y5.44%
OM growth 3Y3.86%
OM growth 5Y3.06%
PM growth 3Y8.69%
PM growth 5Y0.55%
GM growth 3Y3.54%
GM growth 5Y2.81%
F-Score7
Asset Turnover0.11
Health
Industry RankSector Rank
Debt/Equity 0.31
Debt/FCF 4.43
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage 4.56
Cash Conversion N/A
Profit Quality 155.24%
Current Ratio 5.39
Quick Ratio 5.39
Altman-Z 2.17
F-Score7
WACC6.46%
ROIC/WACC0.59
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)0.15%
Cap/Sales(5y)N/A
Profit Quality(3y)316.56%
Profit Quality(5y)248.29%
High Growth Momentum
Growth
EPS 1Y (TTM)128.57%
EPS 3Y-23%
EPS 5Y-18.39%
EPS Q2Q%-55.56%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-13.03%
Revenue growth 3Y-29.62%
Revenue growth 5Y-19%
Sales Q2Q%-13.89%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y12.44%
EBIT growth 3Y-26.9%
EBIT growth 5Y-16.51%
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y7167.44%
FCF growth 3Y-34.63%
FCF growth 5Y-21.8%
OCF growth 1Y6913.33%
OCF growth 3Y-34.43%
OCF growth 5Y-21.69%